InMed Pharmaceuticals (INM) Goodwill & Intangibles (2020 - 2026)
InMed Pharmaceuticals (INM) posted quarterly Goodwill & Intangibles of $1.5 million for Q1 2026, down 9.79% year-over-year from $1.7 million in Q1 2025, and down 2.61% quarter-over-quarter from $1.5 million in Q4 2025.
InMed Pharmaceuticals (INM) Goodwill & Intangibles (2020 - 2026) Analysis & Trends
InMed Pharmaceuticals' Goodwill & Intangibles history runs 7 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 9.79% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (down 9.79% YoY), while the FY2025 annual figure was $1.6 million, down 44.64% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $1.5 million, down from $1.5 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $4.4 million in Q1 2022, with the low at $1.2 million in Q2 2023.
- The 5-year median for Goodwill & Intangibles is $1.7 million (2024), against an average of $2.1 million.
- The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles soared 152.15% in 2022, then tumbled 64.07% in 2023.
- InMed Pharmaceuticals' Goodwill & Intangibles stood at $2.0 million in 2022, then surged by 44.43% to $2.9 million in 2023, then slumped by 41.89% to $1.7 million in 2024, then dropped by 9.56% to $1.5 million in 2025, then declined by 2.61% to $1.5 million in 2026.
- Business Quant data shows INM's Goodwill & Intangibles at $1.5 million in Q1 2026, $1.5 million in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | InMed Pharmaceuticals | 6.36 Mn | 1.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.50 Mn |
| Dec 31, 2025 | 1.54 Mn |
| Sep 30, 2025 | 1.58 Mn |
| Jun 30, 2025 | 1.62 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 1.74 Mn |
| Jun 30, 2024 | 2.93 Mn |
| Mar 31, 2024 | 1.82 Mn |
| Dec 31, 2023 | 2.93 Mn |
| Sep 30, 2023 | 2.93 Mn |
| Jun 30, 2023 | 1.17 Mn |
| Mar 31, 2023 | 1.99 Mn |
| Dec 31, 2022 | 2.03 Mn |
| Sep 30, 2022 | 1.74 Mn |
| Jun 30, 2022 | 3.25 Mn |
| Mar 31, 2022 | 4.38 Mn |
| Dec 31, 2021 | 3.76 Mn |
| Sep 30, 2021 | 1.04 Mn |
| Jun 30, 2021 | 2.80 Mn |